OJCD  Vol.6 No.3 , September 2016
Amyloïdosis Complicating Behcet’s Disease
Abstract: Background: Behcet’s disease is a vasculitis affecting several organs. A renal involvement is rarely described. It is most of the time about a renal amyloidosis. Patients and methods: It is a descriptive retrospective study concerning the patients followed in our department for a Behcet’s disease having presented a renal amyloidosis. Results: It is about 4 men with average age of 38.25 years old. The renal involvement was revealed after an average delay of 5.7 years by a nephrotic syndrome in all cases. A renal insufficiency was noted in 3 cases with an average serum creatinine of 587 μmol/l (127 - 1490). The type of the amyloidosis was AA in 2 cases. The treatment contained colchicines in every case. The evolution was marked by the worsening of the renal function leading to end stage renal disease in 3 cases. Death occurred in 1 case and one patient lost to follow up. Discussion: Renal amyloidosis can complicate the evolution of a Behcet’s disease. It occurs generally 1 to 10 years after the beginning of the disease. Once installed, it evolves generally towards the chronic renal insufficiency and can condition the forecast of this affection. Conclusion: Amyloidosis is a rare complication of the Behcet’s disease. Its screening is so desirable to improve the renal prognosis of these patients.
Cite this paper: Harzallah, A. , El Jery, H. , Hajji, M. , Mami, I. , Goucha, R. , Turki, S. , Hamida, F. , Mahfoudhi, M. and Abdallah, T. (2016) Amyloïdosis Complicating Behcet’s Disease. Open Journal of Clinical Diagnostics, 6, 42-46. doi: 10.4236/ojcd.2016.63008.

[1]   Saadoun, D. and Wechsler, B. (2012) Behcet’s Disease. Orphanet Journal of Rare Diseases, 7, 20.

[2]   Yazici, Y., Yurdakul, S. and Yazici, H. (2010) Behcet’s Syndrome. Current Rheumatology Reports, 12, 429-435.

[3]   Akpolat, T., Dilek, M., Aksu, K., Keser, G., Toprak, O., Cirit, M., et al. (2008) Renal Behcet’s Disease: An Update. Seminars in Arthritis and Rheumatism, 38, 241-248.

[4]   Akpolat, I., Akpolat, T., Danaci, M., Baris, Y.S., Kaya, N. and Kandemir, B. (1997) Behcet’s Disease and Amyloidosis. Review of the Literature. Scandinavian Journal of Rheumatology, 26, 477-479.

[5]   International Study Group for Behcet’s Disease (1990) Criteria for Diagnosis of Behcet’s Disease. The Lancet, 335, 1078-1080.

[6]   Akpolat, T., Akkoyunlu, M., Akpolat, I., Dilek, M., Odabas, A.R. and Ozen, S. (2002) Renal Behcet’s Disease: A Cumulative Analysis. Seminars in Arthritis and Rheumatism, 31, 317-337.

[7]   Melikoglu, M., Altiparmak, M.R., Freski, I., Tunc, R., Yurdakul, S. and Hamuryudan, V. (2001) A Reappraisal of Amyloidosis in Behcet’s Syndrome. Rheumatology, 40, 212-215.

[8]   Kosemehmetoglu, K. and Baydar, D.E. (2013) Renal Amyloidosis in Behcet’s Disease: Clinicopathologic Features of 8 Cases. International Urology and Nephrology, 45, 785-794.

[9]   Ben Ghorbel, I., Bel Feki, N., Lamloum, M. and Houman, M.H. (2015) Amyloidosis in Behcet’s Disease. Saudi Journal of Kidney Diseases and Transplantation, 26, 132-134.

[10]   Akpolat, T., Akpolat, I. and Kandemir, B. (2000) Behcet’s Disease and AA-Type Amyloidosis. American Journal of Nephrology, 20, 68-70.

[11]   Livneh, A., Zemer, D., Langevitz, P., Shemer, J., Sohar, E. and Pras, M. (1993) Colchicine in the Treatment of AA and AL Amyloidosis. Seminars in Arthritis and Rheumatism, 23, 206-214.